Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - levetiracetam - tablet - 500mg

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - levetiracetam - tablet - 1gram

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - levetiracetam - tablet - 750mg

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - levetiracetam - solution for infusion - 100mg/1ml

Європейський Союз - англійська - EMA (European Medicines Agency)

ucb pharma sa - levetiracetam - epilepsy - antiepileptics, - keppra is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.keppra is indicated as adjunctive therapy:in the treatment of partial-onset seizures with or without secondary generalisation in adults, children and infants from one month of age with epilepsy;in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy;in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - levetiracetam - oral solution - 100mg/1ml

Європейський Союз - англійська - EMA (European Medicines Agency)

ucb pharma ltd - sodium oxybate - cataplexy; narcolepsy - other nervous system drugs - treatment of narcolepsy with cataplexy in adult patients.